Parkinson's Disease Diagnosis Using Neostriatum Radiomic Features Based on T2-Weighted Magnetic Resonance Imaging

Abstract

Background: Parkinson's disease (PD) is a neurodegenerative disease in which the neostriatum, including the caudate nucleus (CN) and putamen (PU), has an important role in the pathophysiology. However, conventional magnetic resonance imaging (MRI) lacks sufficient specificity to diagnose PD. Therefore, the study's aim was to investigate the feasibility of using a radiomics approach to distinguish PD patients from healthy controls on T2-weighted images of the neostriatum and provide a basis for the clinical diagnosis of PD. Methods: T2-weighted images from 69 PD patients and 69 age-and sex-matched healthy controls were obtained on the same 3.0T MRI scanner. Regions of interest (ROIs) were manually placed at the CN and PU on the slices showing the largest respective sizes of the CN and PU. We extracted 274 texture features from each ROI and then used the least absolute shrinkage and selection operator regression to perform feature selection and radiomics signature building to identify the CN and PU radiomics signatures consisting of optimal features. We used a receiver operating characteristic curve analysis to assess the diagnostic performance of two radiomics signatures in a training group and estimate the generalization performance in the test group. Results: There were no significant differences in the demographic and clinical characteristics between the PD patients and healthy controls. The CN and PU radiomics signatures were built using 12 and 7 optimal features, respectively. The performance of the two radiomics signatures to distinguish PD patients from healthy controls was good. In the training and test groups, the AUCs of the CN radiomics signatures were 0.9410 (95% confidence interval [CI]: 0.8986-0.9833) and 0.7732 (95% CI: 0.6292-0.9173), respectively, and the AUCs of the PU radiomics signature were 0.8767 (95% CI: 0.8066-0.9469) and 0.7143 (95% CI: 0.5540-0.8746), respectively. Vertl_GlevNonU_R appeared simultaneously in both the CN and PU radiomics signatures as an optimal feature. A t-test analysis revealed significantly higher levels of texture values of the CN and PU in the PD patients than healthy controls (P < 0.05). Conclusion: Neostriatum radiomics signatures achieved good diagnostic performance for PD and potentially could serve as a basis for the clinical diagnosis of PD.

CT Angiography-Based Radiomics for Classification of Intracranial Aneurysm Rupture

“…Second, although the radiomics calculation was automatic, the ROI segmentation was manual, which is prone to interoperator variability and hinders the clinical application of radiomics. Future utility of automatic segmentation might reduce the interoperator variability and improve the clinical feasibility of radiomics ( 31 ). Additionally, we had a heterogeneous data recruited from two institutions with CTA images acquired by four different scanners comprising various protocols.…”

Aberrant functional connectivity and activity in Parkinson’s disease and comorbidity with depression based on radiomic analysis

“…The combination of radiomics features and convolutional neural networks (CNN) can increase the diagnostic accuracy (Ortiz et al., 2019). Other radiomic analysis focusing on longitudinal SPECT images and T2‐weighted MRI can also enhance the prediction accuracy of PD (Liu et al., 2020; Rahmim et al., 2017). A radiomic study based on PET/CT images extracted high‐order features and trained a SVM model to classify PD and HC subjects, and the results demonstrated that the radiomic method combined with SVM could distinguish PD from HC (Wu et al., 2019).…”

Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics

“…Although conventional MRI lacks specificity as a diagnostic aid for PD, 70 a large number of patients show structural microlesions in the basal ganglia, with progressive reductions in whole gray matter, and a volumetric decrease in the caudate, putamen, accumbens, and amygdala. 71,72 In our PD sample, over 80% of patients showed abnormal MRI.…”